A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
Conclusions The combination of tivantinib with temsirolimus appears to be well tolerated with evidence of clinical activity.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Anemia | Anorexia | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Drugs & Pharmacology | Eating Disorders & Weight Management | Investigational New Drugs | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Pain | Skin Cancer | Squamous Cell Carcinoma | Study | Toxicology